Medicamen Organics Financials

NSE: MEDIORG

₹26.50

₹0.00 (0.00%)

As on 09-Sep-2026 09:48IST

Market cap

₹39 Cr

Revenue (TTM)

₹38 Cr

P/E Ratio

--

P/B Ratio

0.9

Div. Yield

0 %

Income Statement (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Operating Revenue	38.19	25.27	--	--	--	--
Total Income	38.28	26.34	--	--	--	--
Total Expenditure	31.57	20.53	--	--	--	--
EBITDA	6.62	4.74	--	--	--	--
Depreciation	0.74	0.72	--	--	--	--
EBIT	5.88	4.02	--	--	--	--
Interest	0.54	0.65	--	--	--	--
Other Income	0.10	1.07	--	--	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	5.43	4.44	--	--	--	--
Provision for Tax	1.38	1.81	--	--	--	--
Profit after Tax	4.05	2.62	--	--	--	--
Minority Interest	--	--	--	--	--	--
Share of Associate	--	--	--	--	--	--
Consolidated Profit	4.05	2.62	--	--	--	--

Liabilities (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Shareholder's Funds	30.13	15.26	--	--	--	--
Minority Interest	0.35	--	--	--	--	--
Non-Current Liabilities	1.57	1.56	--	--	--	--
Current Liabilities	27.16	21.62	--	--	--	--
Total Liabilities	59.21	38.44	--	--	--	--

Assets (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Non-Current Assets	13.78	11.13	--	--	--	--
Current Assets	45.43	27.31	--	--	--	--
Total Assets	59.21	38.44	--	--	--	--
Total Debt*	12.35	12.66	--	--	--	--
Net Current Assets	18.28	5.69	--	--	--	--
Contingent Liabilities	2.46	2.01	--	--	--	--

Cashflow (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Cash From Operating Activities	-4.54	-3.66	--	--	--	--
Cash Flow from Investing Activities	-2.35	-0.34	--	--	--	--
Cash from Financing Activities	10.47	4.01	--	--	--	--
Net Cash Inflow / Outflow	3.58	0.01	--	--	--	--

Financials Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Adjusted EPS (₹)	3.46	3.05	--	--	--	--
Cash EPS (₹)	4.09	3.89	--	--	--	--
Adjusted Book Value (₹)	25.11	17.74	--	--	--	--
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	-3.88	-4.26	--	--	--	--
Free Cash Flow per Share (₹)	-7.43	-6.08	--	--	--	--

Profitability Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
ROCE (%)	16.97	18.21	--	--	--	--
ROE (%)	18.13	17.20	--	--	--	--
ROA (%)	8.29	6.83	--	--	--	--
EBIT Margin (%)	15.39	15.90	--	--	--	--
Net Margin (%)	10.57	9.96	--	--	--	--
Cash Profit Margin (%)	12.53	13.23	--	--	--	--

Growth Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Revenue Growth (%)	51.11	--	--	--	--	--
EBIT Growth (%)	46.30	--	--	--	--	--
Net Profit Growth (%)	54.22	--	--	--	--	--
EPS Growth (%)	13.36	--	--	--	--	--
Book Value Growth (%)	92.53	--	--	--	--	--

Valuation Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Price / Earnings	6.27	--	--	--	--	--
Price / Book Value	0.86	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	5.01	3.57	--	--	--	--
Close Price (₹)	21.70	--	--	--	--	--
High Price (₹)	159.40	--	--	--	--	--
Low Price (₹)	19.60	--	--	--	--	--
Market Cap (₹ Cr)	25.39	--	--	--	--	--

Solvency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debt to Equity	0.42	0.83	--	--	--	--
Short term debt to equity ratio	0.40	0.81	--	--	--	--
Current Ratio	1.67	1.26	--	--	--	--
Quick Ratio	1.40	0.98	--	--	--	--
Interest Coverage	11.00	7.85	--	--	--	--

Operating Efficiency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debtors to sales (%)	67.70	66.08	--	--	--	--
Asset Turnover	0.78	0.66	--	--	--	--
Receivable days	203.36	241.20	--	--	--	--
Inventory Days	65.15	88.72	--	--	--	--
Payable days	286.26	281.84	--	--	--	--
Cash Conversion Cycle	-17.75	48.07	--	--	--	--